Metformin is synthetically lethal with glucose withdrawal in cancer cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin is synthetically lethal with glucose withdrawal in cancer cells
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 15, Pages 2782-2792
Publisher
Informa UK Limited
Online
2012-08-01
DOI
10.4161/cc.20948
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fasting and cancer treatment in humans: A case series report
- (2016) Fernando M. Safdie et al. Aging-US
- Metformin and the ATM DNA damage response (DDR): Accelerating the onset of stress-induced senescence to boost protection against cancer
- (2016) Javier A. Menendez et al. Aging-US
- Gerosuppressant Metformin: less is more
- (2016) Javier A. Menendez et al. Aging-US
- Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
- (2015) Pasha Apontes et al. Oncotarget
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Energy metabolism plasticity enables stemness programs
- (2012) Clifford D.L. Folmes et al. Annals of the New York Academy of Sciences
- Metformin and Cancer Stem Cells: Old Drug, New Targets
- (2012) F. Bednar et al. Cancer Prevention Research
- Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
- (2012) M. Tamada et al. CANCER RESEARCH
- Metformin and reprogramming into iPSCs
- (2012) Manuel Serrano CELL CYCLE
- Metformin lowers the threshold for stress-induced senescence: A role for the microRNA-200 family and miR-205
- (2012) Sílvia Cufí et al. CELL CYCLE
- Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells
- (2012) Alejandro Vazquez-Martin et al. CELL CYCLE
- Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
- (2012) Xin-Sheng Deng et al. CELL CYCLE
- Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents
- (2012) Guofang Chen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin: A Diabetes Drug for Cancer, or a Cancer Drug for Diabetics?
- (2012) Matthew Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in cancer: translational challenges
- (2012) Ryan J O Dowling et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
- (2012) C. Lee et al. Science Translational Medicine
- Radiation-Induced Reprogramming of Breast Cancer Cells
- (2012) Chann Lagadec et al. STEM CELLS
- Cancer metabolism: current perspectives and future directions
- (2012) C Muñoz-Pinedo et al. Cell Death & Disease
- Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
- (2012) Matthew J. Martin et al. Cancer Discovery
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
- (2012) Chang W. Song et al. Scientific Reports
- Sensing of energy and nutrients by AMP-activated protein kinase
- (2011) D Grahame Hardie AMERICAN JOURNAL OF CLINICAL NUTRITION
- Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
- (2011) Sirwan Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Metformin activates an Ataxia Telangiectasia Mutated (ATM)/Chk2-regulated DNA damage-like response
- (2011) Alejandro Vazquez-Martin et al. CELL CYCLE
- mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging
- (2011) Javier A. Menendez et al. CELL CYCLE
- Synthetic lethality of PARP inhibition in cancers lackingBRCA1andBRCA2mutations
- (2011) Konstantin J. Dedes et al. CELL CYCLE
- Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
- (2011) Clifford D.L. Folmes et al. Cell Metabolism
- The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming
- (2011) Athanasia D Panopoulos et al. CELL RESEARCH
- The role of LKB1 and AMPK in cellular responses to stress and damage
- (2011) Angela Alexander et al. FEBS LETTERS
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models
- (2011) J.-H. Cheong et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2011) Mary Leung et al. MOLECULAR MEDICINE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Harnessing synthetic lethal interactions in anticancer drug discovery
- (2011) Denise A. Chan et al. NATURE REVIEWS DRUG DISCOVERY
- Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients
- (2011) C Lee et al. ONCOGENE
- The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling
- (2011) W van Veelen et al. ONCOGENE
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Optical imaging of metabolism in HER2 overexpressing breast cancer cells
- (2011) Alex Walsh et al. Biomedical Optics Express
- The combination of metformin and 2 deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells
- (2010) Issam Ben Sahra et al. Autophagy
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- (2010) Alejandro Vazquez-Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastasis: cancer cell’s escape from oxidative stress
- (2010) Giovambattista Pani et al. CANCER AND METASTASIS REVIEWS
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases
- (2010) Heather A. Hirsch et al. CANCER CELL
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of research
- (2010) Ana Bosch et al. CANCER TREATMENT REVIEWS
- Homologous recombination in cancer development, treatment and development of drug resistance
- (2010) T. Helleday CARCINOGENESIS
- Activation of AMPK is necessary for killing cancer cells and sparing cardiac cells
- (2010) Scott A. Shell et al. CELL CYCLE
- Fasting and differential chemotherapy protection in patients
- (2010) Lizzia Raffaghello et al. CELL CYCLE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
- (2010) Begoña Martin-Castillo et al. CELL CYCLE
- Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
- (2010) A. Vazquez-Martin et al. CURRENT MOLECULAR MEDICINE
- Glucose metabolism in cancer cells
- (2010) Alessandro Annibaldi et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Hypoxia and energetic tumour metabolism
- (2010) M Christiane Brahimi-Horn et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond
- (2010) Lev M Berstein Future Oncology
- Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
- (2010) Jiangyong Ouyang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in 2-fluoro-2-deoxy-d-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab
- (2010) Richard W. Cheyne et al. NUCLEAR MEDICINE AND BIOLOGY
- Sugar-free approaches to cancer cell killing
- (2010) N El Mjiyad et al. ONCOGENE
- ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS
- (2010) A. Alexander et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Senescence-Related Mitochondrial/Oxidative Stress Pathway is Repressed in Human Induced Pluripotent Stem Cells
- (2010) Alessandro Prigione et al. STEM CELLS
- Targeting the Resistance of Pancreatic Cancer Cells to Nutrient Deprivation: Anti-Austerity Compounds
- (2010) Jakob Magolan et al. Current Drug Delivery
- LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
- (2009) R. J. Shaw Acta Physiologica
- The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy
- (2009) A. Vazquez-Martin et al. ANNALS OF ONCOLOGY
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Quantitative Metabolome Profiling of Colon and Stomach Cancer Microenvironment by Capillary Electrophoresis Time-of-Flight Mass Spectrometry
- (2009) A. Hirayama et al. CANCER RESEARCH
- mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb®)
- (2009) Alejandro Vázquez-Martín et al. Clinical & Translational Oncology
- Tumor suppressors and cell metabolism: a recipe for cancer growth
- (2009) R. G. Jones et al. GENES & DEVELOPMENT
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Cancer stem cells and angiogenesis
- (2009) Rolf Bjerkvig et al. SEMINARS IN CANCER BIOLOGY
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
- (2008) Ralph J. DeBerardinis et al. Cell Metabolism
- Brick by brick: metabolism and tumor cell growth
- (2008) Ralph J DeBerardinis et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy
- (2008) L. Raffaghello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AMPK: a metabolic gauge regulating whole-body energy homeostasis
- (2008) Ricardo Lage et al. TRENDS IN MOLECULAR MEDICINE
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started